SCHEDULE 13D/A: Bleichroeder LP Increases Stake in Scientific Industries, Acquiring Additional Shares and Warrants

Bleichroeder LP and its affiliates have increased their beneficial ownership in Scientific Industries, Inc. to 22.69% through a new securities purchase agreement for $250,000, acquiring 250,000 shares and warrants.

Summary

• This document is Amendment No. 3 to the Schedule 13D originally filed by Bleichroeder LP, Bleichroeder Holdings LLC, and Andrew Gundlach (the "Reporting Persons") concerning their beneficial ownership of Common Stock in Scientific Industries, Inc. (the "Issuer").
• On April 18, 2025, the Issuer entered into a Securities Purchase Agreement with funds managed by the Reporting Persons.
• Under this agreement, the Issuer issued and sold 250,000 Shares and Warrants to purchase an additional 250,000 Shares for an aggregate purchase price of $250,000.
• The Warrants are exercisable at a price of $1.00 per Share.
• As of the filing date of this Amendment No. 3, the Reporting Persons beneficially own a total of 2,965,026 Shares.
• This ownership represents 22.69% of the Issuer's outstanding Shares, a calculation that includes shares issuable upon the exercise of the Warrants.
• The percentage is based on 10,503,599 shares reported outstanding as of March 27, 2025, an additional 1,050,000 shares issued on April 18, 2025, and 1,511,675 shares issuable from warrants.
• The Reporting Persons maintain sole voting and dispositive power over all 2,965,026 beneficially owned Shares.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive. While the capital raise and increased stake by a significant investor are positive signs of confidence, the low warrant exercise price ($1.00) could imply a lower valuation or a need for capital at a discount, which introduces a degree of caution.

Positives

• The increased investment by Bleichroeder LP, a significant existing shareholder, signals continued confidence in Scientific Industries, Inc.'s future prospects.
• The capital infusion of $250,000 provides additional funding to the Issuer, which can be utilized for operational needs or strategic initiatives.

Negatives

• The issuance of new shares and warrants could lead to dilution for existing shareholders, potentially reducing their proportional ownership.
• The warrant exercise price of $1.00 per share is relatively low, which might suggest a lower valuation for the company's stock or a need for capital at a discount.

Risks

• Potential dilution of existing shareholders' equity due to the issuance of new shares and the future exercise of warrants.
• The low warrant exercise price of $1.00 per share could be perceived as a risk if it indicates underlying financial challenges or a significantly depressed stock valuation.

Future Outlook

The document does not provide explicit forward-looking statements or guidance from the Issuer or Reporting Persons beyond the details of the securities purchase.

Industry Context

This filing indicates a significant, continued investment by a key shareholder in Scientific Industries, Inc., suggesting a belief in the company's long-term prospects despite the low warrant exercise price. Such transactions are common in industries where companies may require capital for growth or operational needs, and existing large shareholders often participate to maintain or increase their influence and stake.

Comparison to Industry Standards

• The document does not provide sufficient information to make specific comparisons to industry standards, comparable companies, or projects. It primarily details a change in beneficial ownership and a capital infusion from an existing significant investor.

Related Party Transactions

• The Securities Purchase Agreement was entered into with funds managed by the Reporting Persons, who are already significant shareholders, indicating a related-party transaction.

Stakeholder Impact

• Shareholders: Potential dilution from the issuance of new shares and warrants. However, the capital infusion could support company operations and growth.
• Company (Issuer): Receives $250,000 in capital, which can be used for operations or strategic initiatives.

Next Steps

• The document does not explicitly mention future actions, events, or milestones beyond the completion of the described securities purchase.

Key Dates

Recommendation

Keywords

Scientific Industries Inc., Bleichroeder LP, Schedule 13D/A, SEC filing, beneficial ownership, equity investment, warrants, share dilution, capital raise, investment firm, Andrew Gundlach